Long-Term Changes in Health-Related Quality of Life and Economic Burden After a SARS-CoV-2 Infection: Analysis of the Long COVID Prospective Cohort Study in Nairobi

dc.contributor.authorBen Â.J.
dc.contributor.authorKisiangani I.
dc.contributor.authorKinya I.
dc.contributor.authorWynberg E.
dc.contributor.authorde Jong M.D.
dc.contributor.authorSchultsz C.
dc.contributor.authorAsiki G.
dc.contributor.authorVassall A.
dc.contributor.correspondenceBen Â.J.
dc.contributor.otherMahidol University
dc.date.accessioned2026-02-06T18:13:56Z
dc.date.available2026-02-06T18:13:56Z
dc.date.issued2026-05-01
dc.description.abstractObjectives To characterize long-term changes in health-related quality of life (HRQoL) and factors associated with catastrophic expenditures and catastrophic costs after a SARS-CoV-2 infection. Methods Data from 291 participants of the Long COVID Prospective Cohort Study in Nairobi were analyzed. Participants were enrolled between 2022 and 2023 and followed up for 12 months. Possible factors and outcomes (HRQoL, catastrophic expenditures, and catastrophic costs) were measured every 3 months. Changes in outcomes over time were assessed using generalized estimating equations. Results HRQoL was significantly reduced by 11.4% (95% CI −16.3% to −6.5%), 8.6% (95% CI −12.5% to −4.6%), 6.1% (95% CI −10.5% to −1.8%), and 4.1% (95% CI −7.9% to −0.3%) at 6, 9, 12, and 15 months after a positive polymerase chain reaction test, respectively, compared with the period before COVID-19. HRQoL was significantly reduced by 3.3% (95% CI −6.2% to −0.5%), and 10.9% (95% CI −16.5% to −5.3%), respectively, in participants with any COVID-19-related symptoms or fatigue. Older age (odds ratio [OR] 5.83, 95% CI 2.11 to 16.15), no COVID-19 vaccination (OR 5.83, 95% CI 2.11 to 16.15), any COVID-19-related symptoms (OR 2.22, 95% CI 1.15 to 4.28), and pay cut or reduced income due to COVID-19-related symptoms (OR 17.36, 95% CI 2.28 to 132.07) were associated with high odds of experiencing catastrophic expenditures. Severe/critical SARS-CoV-2 infection (OR 4.77, 95% CI 1.72 to 13.25) and fatigue (OR 2.27, 95% CI 1.03 to 4.96) significantly increased the odds of experiencing catastrophic costs, whereas better HRQoL (OR 0.12, 95% CI 0.02 to 0.57) and social support (OR 0.30, 95% CI 0.09 to 0.93) decreased the odds. Conclusions HRQoL remains reduced up to 15 months after a SARS-CoV-2 infection compared with pre-COVID-19 levels, with participants in better health and socioeconomic status less likely to experience catastrophic expenditures and catastrophic costs.
dc.identifier.citationValue in Health Regional Issues Vol.53 (2026)
dc.identifier.doi10.1016/j.vhri.2025.101545
dc.identifier.eissn22121102
dc.identifier.issn22121099
dc.identifier.pmid41259895
dc.identifier.scopus2-s2.0-105022254498
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/114437
dc.rights.holderSCOPUS
dc.subjectPharmacology, Toxicology and Pharmaceutics
dc.subjectMedicine
dc.subjectEconomics, Econometrics and Finance
dc.titleLong-Term Changes in Health-Related Quality of Life and Economic Burden After a SARS-CoV-2 Infection: Analysis of the Long COVID Prospective Cohort Study in Nairobi
dc.typeArticle
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105022254498&origin=inward
oaire.citation.titleValue in Health Regional Issues
oaire.citation.volume53
oairecerif.author.affiliationUniversiteit van Amsterdam
oairecerif.author.affiliationVrije Universiteit Amsterdam
oairecerif.author.affiliationLondon School of Hygiene & Tropical Medicine
oairecerif.author.affiliationKenyatta University
oairecerif.author.affiliationMahidol Oxford Tropical Medicine Research Unit
oairecerif.author.affiliationAfrican Population and Health Research Center
oairecerif.author.affiliationAmsterdam Institute for Global Health and Development

Files

Collections